openPR Logo
Press release

Smart Inhalers Market 2016: OPKO Health, Inc., AstraZeneca plc, GlaxoSmithKline, Propeller Health, Aptar Pharma, Novartis AG, Boehringer Ingelheim | Forecast to 2026

06-05-2019 11:33 AM CET | Health & Medicine

Press release from: persistencemarketresearch.com

Smart Inhalers Market

Smart Inhalers Market

Persistence Market Research has recently developed a report on the Smart Inhalers Market which presents substantial inputs about the market size, market share, regional trends, and profit projection of this business sphere. The report also enlightens users regarding the foremost challenges and existing growth tactics implemented by the leading organizations that constitute the dynamic competitive gamut of this industry.

Get Sample Copy Of This Report @ https://www.persistencemarketresearch.com/samples/26881

A recent market study published by the company – “Smart Inhalers Market: Global Industry Analysis 2015 – 2017 and Forecast 2018 – 2026,” consists of a comprehensive assessment of the most important market dynamics. By conducting a thorough research on the historical as well as current growth parameters of the smart inhalers market, the growth prospects of the market are obtained with maximum precision. The report features unique and salient factors that may have a huge impact on the development of the smart inhalers market during the forecast period. It can help the players to modify their manufacturing and marketing strategies to envisage maximum growth in the smart inhalers in the upcoming years. The report provides detailed information about the current and future growth prospects of the smart inhalers market in the most comprehensive way for better understanding of the readers.

Request For TOC @ https://www.persistencemarketresearch.com/methodology/26881

The Smart Inhalers market report formulated recently by Persistence Market Research evaluates the industry in terms of market size, market share, revenue estimation, and geographical outlook. The study also delivers a precise summary that illustrates the competitive milieu, growth opportunities and application landscape of the Smart Inhalers market depending on the industry’s financial and non-financial impact.

The report on the smart inhalers market offers a comprehensive evaluation of the business opportunities in the smart inhalers market along with insights on the smart inhalers competition blueprint, pricing analysis, epidemiology study, iceberg analysis, list of key distributors, and suppliers in the smart inhalers market for the duration from 2018 to 2026.

The report offers a comprehensive taxonomy of the smart inhalers market on the basis of product type, disease indication, distribution channel, and region. On the basis of product type, the global smart inhalers market has been segmented into DPI-based smart inhalers and MDI-based smart inhalers. On the basis of disease indication, the global smart inhalers market has been segmented into asthma and COPD. On the basis of distribution channel, the global smart inhalers market has been segmented into hospital pharmacies, retail pharmacies, and online pharmacies. From a geographical perspective, the smart inhalers market has been segmented into North America, Latin America, Europe, Asia Pacific (APAC), and Middle East & Africa (MEA).

Get Order Copy Of This Report@ https://www.persistencemarketresearch.com/checkout/26881

Table Of Content:

1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. PMR Research Analysis and Recommendations
1.4. Wheel of Fortune

2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition

3. Smart Inhalers Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis

4. Market Background
4.1. Market Dynamics
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Trends

5. Global Economic Outlook
5.1. Gross Domestic Product by Region & Country, 2016 – 2021
5.2. Medical Devices Sector Outlook
5.3. Healthcare Indicators

6. Key Inclusions
6.1. Disease Epidemiology, by Region
6.2. Pricing Analysis by Region

7. North America Smart Inhalers Market Analysis 2015–2017 and Forecast 2018–2026
Market forecast and analysis in the U.S. and Canada
7.1. Introduction
7.2. Historical Market Value (US$ Mn) Trend Analysis By Country, 2015–2017
7.2.1. U.S.
7.2.2. Canada
7.3. Market Value (US$ Mn) Forecast By Country, 2018–2026
7.4. Historical Market Value (US$ Mn) Analysis By Product Type, 2015–2017
7.4.1. Dry Powder Inhaler (DPI)- based Smart Inhalers
7.4.2. Metered Dose Inhaler (MDI)- based Smart Inhalers
7.5. Market Value (US$ Mn) Forecast By Product Type, 2018–2026
7.6. Historical Market Value (US$ Mn) Analysis By Disease Indication, 2015–2017
7.6.1. Asthma
7.6.2. COPD
7.7. Market Value (US$ Mn) Forecast By Disease Indication, 2018–2026
7.8. Historical Market Value (US$ Mn) Trend Analysis By Distribution Channel, 2015–2017
7.8.1. Hospital Pharmacies
7.8.2. Retail Pharmacies
7.8.3. Online Pharmacies
7.9. Market Value (US$ Mn) Forecast By Distribution Channel, 2018–2026
7.10. Market Attractiveness Analysis
7.10.1. By Country
7.10.2. By Product Type
7.10.3. By Disease Indication
7.10.4. By Distribution Channel
7.11. Drivers and Restraints – Impact Analysis

8. Latin America Smart Inhalers Market Analysis 2015–2017 and Forecast 2018–2026
8.1. Introduction
8.2. Historical Market Value (US$ Mn) Trend Analysis By Country, 2015–2017
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Market Value (US$ Mn) Forecast By Country, 2018–2026
8.4. Historical Market Value (US$ Mn) Analysis By Product Type, 2015–2017
8.4.1. Dry Powder Inhaler (DPI)- based Smart Inhalers
8.4.2. Metered Dose Inhaler (MDI)- based Smart Inhalers
8.5. Market Value (US$ Mn) Forecast By Product Type, 2018–2026
8.6. Historical Market Value (US$ Mn) Analysis By Disease Indication, 2015–2017
8.6.1. Asthma
8.6.2. COPD
8.7. Market Value (US$ Mn) Forecast By Disease Indication, 2018–2026
8.8. Historical Market Value (US$ Mn) Trend Analysis By Distribution Channel, 2015–2017
8.8.1. Hospital Pharmacies
8.8.2. Retail Pharmacies
8.8.3. Online Pharmacies
8.9. Market Value (US$ Mn) Forecast By Distribution Channel, 2018–2026
8.10. Market Attractiveness Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Disease Indication
8.10.4. By Distribution Channel
8.11. Drivers and Restraints – Impact Analysis

9. Europe Smart Inhalers Market Analysis 2015–2017 and Forecast 2018–2026
9.1. Introduction
9.2. Historical Market Value (US$ Mn) Trend Analysis By Country, 2015–2017
9.2.1. Germany
9.2.2. U.K.
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Market Value (US$ Mn) Forecast By Country, 2018–2026
9.4. Historical Market Value (US$ Mn) Analysis By Product Type, 2015–2017
9.4.1. Dry Powder Inhaler (DPI)- based Smart Inhalers
9.4.2. Metered Dose Inhaler (MDI)- based Smart Inhalers
9.5. Market Value (US$ Mn) Forecast By Product Type, 2018–2026
9.6. Historical Market Value (US$ Mn) Analysis By Disease Indication, 2015–2017
9.6.1. Asthma
9.6.2. COPD
9.7. Market Value (US$ Mn) Forecast By Disease Indication, 2018–2026
9.8. Historical Market Value (US$ Mn) Trend Analysis By Distribution Channel, 2015–2017
9.8.1. Hospital Pharmacies
9.8.2. Retail Pharmacies
9.8.3. Online Pharmacies
9.9. Market Value (US$ Mn) Forecast By Distribution Channel, 2018–2026
9.10. Market Attractiveness Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Disease Indication
9.10.4. By Distribution Channel
9.11. Drivers and Restraints – Impact Analysis

10. Asia Pacific Smart Inhalers Market Analysis 2015–2017 and Forecast 2018–2026
10.1. Introduction
10.2. Historical Market Value (US$ Mn) Trend Analysis By Country, 2015–2017
10.2.1. China
10.2.2. Japan
10.2.3. India
10.2.4. Australia and New Zealand
10.2.5. ASEAN
10.2.6. Rest of Asia Pacific
10.3. Market Value (US$ Mn) Forecast By Country, 2018–2026
10.4. Historical Market Value (US$ Mn) Analysis By Product Type, 2015–2017
10.4.1. Dry Powder Inhaler (DPI)- based Smart Inhalers
10.4.2. Metered Dose Inhaler (MDI)- based Smart Inhalers
10.5. Market Value (US$ Mn) Forecast By Product Type, 2018–2026
10.6. Historical Market Value (US$ Mn) Analysis By Disease Indication, 2015–2017
10.6.1. Asthma
10.6.2. COPD
10.7. Market Value (US$ Mn) Forecast By Disease Indication, 2018–2026
10.8. Historical Market Value (US$ Mn) Trend Analysis By Distribution Channel, 2015–2017
10.8.1. Hospital Pharmacies
10.8.2. Retail Pharmacies
10.8.3. Online Pharmacies
10.9. Market Value (US$ Mn) Forecast By Distribution Channel, 2018–2026
10.10. Market Attractiveness Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Disease Indication
10.10.4. By Distribution Channel
10.11. Drivers and Restraints – Impact Analysis

11. Middle East & Africa Smart Inhalers Market Analysis 2015–2017 and Forecast 2018–2026
11.1. Introduction
11.2. Historical Market Value (US$ Mn) Trend Analysis By Country, 2015–2017
11.2.1. GCC Countries
11.2.2. South Africa
11.2.3. Rest of MEA
11.3. Market Value (US$ Mn) Forecast By Country, 2018–2026
11.4. Historical Market Value (US$ Mn) Analysis By Product Type, 2015–2017
11.4.1. Dry Powder Inhaler (DPI)- based Smart Inhalers
11.4.2. Metered Dose Inhaler (MDI)- based Smart Inhalers
11.5. Market Value (US$ Mn) Forecast By Product Type, 2018–2026
11.6. Historical Market Value (US$ Mn) Analysis By Disease Indication, 2015–2017
11.6.1. Asthma
11.6.2. COPD
11.7. Market Value (US$ Mn) Forecast By Disease Indication, 2018–2026
11.8. Historical Market Value (US$ Mn) Trend Analysis By Distribution Channel, 2015–2017
11.8.1. Hospital Pharmacies
11.8.2. Retail Pharmacies
11.8.3. Online Pharmacies
11.9. Market Value (US$ Mn) Forecast By Distribution Channel, 2018–2026
11.10. Market Attractiveness Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Disease Indication
11.10.4. By Distribution Channel
11.11. Drivers and Restraints – Impact Analysis

12. Forecast Factors: Relevance and Impact

13. Forecast Assumptions

14. Competition Analysis
14.1. Competition Dashboard
14.2. Company Deep Dive
14.2.1. OPKO Health, Inc.
14.2.2. AstraZeneca plc
14.2.3. GlaxoSmithKline
14.2.4. Propeller Health
14.2.5. Aptar Pharma
14.2.6. Novartis AG
14.2.7. Boehringer Ingelheim
14.2.8. Teva Pharmaceuticals
14.2.9. H&T Presspart Manufacturing Ltd.
14.2.10. Sensirion AG
14.2.11. Cohero Health, Inc.

15. Global Smart Inhalers Market Analysis 2015–2017 and Forecast 2018–2026, By Region
15.1. Introduction/Key Findings
15.2. Historical Market Value (US$ Mn) Analysis By Region, 2015–2017
15.3. Market Value (US$ Mn) By Region, 2018–2026
15.3.1. North America
15.3.2. Latin America
15.3.3. Europe
15.3.4. Asia Pacific
15.3.5. Middle East & Africa
15.4. Market Attractiveness Analysis By Region

16. Global Smart Inhalers Analysis 2015–2017 and Forecast 2018–2026, By Product Type
16.1. Introduction/Key Findings
16.2. Historical Market Value (US$ Mn) Analysis By Product Type, 2015–2017
16.2.1. Dry Powder Inhaler (DPI)- based Smart Inhalers
16.2.2. Metered Dose Inhaler (MDI)- based Smart Inhalers
16.3. Market Value (US$ Mn) Forecast By Product Type, 2018–2026
16.4. Market Attractiveness Analysis By Product Type

17. Global Smart Inhalers Analysis 2015–2017 and Forecast 2018–2026, By Disease Indication
17.1. Introduction/Key Findings
17.2. Historical Market Value (US$ Mn) Analysis By Disease Indication, 2015–2017
17.2.1. Asthma
17.2.2. COPD
17.3. Market Value (US$ Mn) Forecast By Disease Indication, 2018–2026
Market Attractiveness Analysis By Disease Indication

18. Global Smart Inhalers Market Analysis 2015–2017 and Forecast 2018–2026, By Distribution Channel
18.1. Historical Market Value (US$ Mn) Trend Analysis By Distribution Channel, 2015–2017
18.1.1. Hospital Pharmacies
18.1.2. Retail Pharmacies
18.1.3. Online Pharmacies
18.2. Market Value (US$ Mn) Forecast By Distribution Channel, 2018–2026
18.3. Market Attractiveness Analysis By Distribution Channel

19. Global Smart Inhalers Market Analysis 2015–2017 and Forecast 2018–2026
19.1. Market Value Share Analysis By All Segment
19.2. Y-o-Y Growth Analysis By All Segment
19.3. Absolute $ Opportunity

20. Assumptions and Acronyms Used

21. Research Methodology

Contact us:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: www.persistencemarketresearch.com

About us:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Smart Inhalers Market 2016: OPKO Health, Inc., AstraZeneca plc, GlaxoSmithKline, Propeller Health, Aptar Pharma, Novartis AG, Boehringer Ingelheim | Forecast to 2026 here

News-ID: 1765350 • Views:

More Releases from persistencemarketresearch.com

Innovation-Based Discernment To Drive The Foil Shavers Market
Innovation-Based Discernment To Drive The Foil Shavers Market
Personal appearance has taken paramount importance in the lives of consumers. Proper grooming and professional appearance have become important attributes to gain respect at the workplace. The way people carry themselves creates an impression on co-workers and the management. The pressure and interest of looking good is equally important to both, men and women. Variations offered by trimmers and shavers have taken up the onus to drive the foil shavers
Alcoholic Hepatitis Therapeutic Market Rugged Expansion Foreseen by 2017 to 2025
Alcoholic Hepatitis Therapeutic Market Rugged Expansion Foreseen by 2017 to 2025
Alcoholic hepatitis is a kind of liver disease usually affects people who are used to be heavy drinkers. It can cause short and long-term liver damage. Liver is a major organ of body functions to remove poisons such as alcohol from blood. It’s damaged by long time heavy drinking of alcohol. Usually occur in 30% of long- time alcohol drinkers. Asymptomatic steatohepatitis is also as alcoholic hepatitis the term is
Advanced Meniscal Fixation Devices Market Continuing to Show Billion Dollar Growth According to 'Persistence Market Research'
Advanced Meniscal Fixation Devices Market Continuing to Show Billion Dollar Grow …
Meniscal fixation is minimally invasive surgical procedure is used to reconstruct torn meniscus. Meniscus functions include distribution and load transmission, joint stability, neuromuscular proprioception and joint nutrition. Meniscal tears are symptomatic and irreparable and meniscal fixation devices are used to remove unstable fragments. Meniscal repair is performed only during longitudinal tears (>10 mm), tears without deformity or secondary degeneration, and others. Meniscal fixation devices are used arthroscopic repair or
Liniments Rubs Market segmentation by key players - Liniments & Rubs Market are Haw Par Corporation Limited., Procter & Gamble, GSK group of companies, Amrutanjan Health Care Ltd. and others. The companies are mainly focusing on intense marketing to conve
Liniments Rubs Market segmentation by key players - Liniments & Rubs Market are …
Liniments are liquid dosage forms which are used relieve pain and stiffness during arthritis, sore muscular aches, and muscle strains. Liniments & rubs are well absorbed through the skin and have a high bioavailability. Liniment vehicles depend on the type of action (counterirritants, massage, and rubefacient) and solubility of desired compounds. They can be used as irritants, analgesics, anti-inflammatory, astringents, and fungicidal. Rubefacient liniments are used for vasodilation and hyperthermia

All 5 Releases


More Releases for Inhaler

Increasing Number Of Launches In Generic Version Of Budesonide Inhaler Drive The …
Budesonide is an artificial glucocorticoid steroid related to the naturally-occurring hormone, cortisol or hydrocortisone, which is produced in the adrenal glands. It is used for treating asthma. Budesonide is sold under the brand name Pulmicort. Each budesonide inhaler is designed to provide 60 to 120 inhalations depending on the device. Increasing air population is expected to lead to high prevalence of asthma worldwide. According to World Health Organization (WHO), asthma
Global Digital Dose Inhaler Market Insights, Forecast
Digital Dose Inhaler is a kind of medical instrument. Digital Dose Inhaler enable patients to the number of tracking has consumed doses. The global Digital Dose Inhaler market is valued at 1790 million US$ in 2018 and will reach 3540 million US$ by the end of 2025, growing at a CAGR of 8.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the
Global Inhaler Market Research and Forecast 2018-2023
“Inhalers- a faster and better way to deliver respiratory medication” Orion Market Research (OMR) recently published a market research report on global inhaler market. It is forecasted that the market is augmenting with a significant CAGR during forecast period 2018-2023. The market is augmenting due to rising prevalence of respiratory disease, increasing air pollution and number of smokers. The global inhaler market is segmented by device, type, application and end-user. The
Dry Powder Inhaler Market Report 2018: Segmentation by Product (Single Dose Dry …
Global Dry Powder Inhaler market research report provides company profile for Astrazeneca Plc., 3M Company, GlaxoSmithKline Plc, Novartis AG, Cipla Ltd., Teva Pharmaceutical Industries Limited, Boehringer Ingelheim GmbH, Chiesi Farmaceutici S.p.A., MannKind Corporation and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and
The Inhaler Devices has Driven The Market for Global Asthma Inhaler Device Marke …
Market Research Future published a Half - Cooked research report on “Global Asthma Inhaler Device Market Research Report- Forecast To 2022” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2022. Adherium limited, AstraZeneca, Boehringer Ingelheim GmbH, Chiesi Farmaceutici S.p.A., GSK plc, Propeller Health, and Teva Pharmaceutical Industries Ltd. and others are some of the prominent players at the forefront of competition in the Global Asthma Inhaler Devices Market and
Asthma Inhaler Device Market by Metered Dose, Spacer and Dry Powder Type Inhaler …
The Worldwide Asthma Inhaler Device Market report provides various factors- price analysis, supply chain analysis, porters five force analysis etc. The report provides key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market Browse Complete 90 Pages Report enabled with Respective Tables and Figures is Available @ https://www.marketresearchfuture.com/reports/asthma-inhaler-device-market . Asthma is a type of inflammatory disease of the lungs. It